European Medicines Agency Begins Review Of Heart Risks From Common Pain Killers
by Zangani • 10 November 2011 • Pain News
The European Medicines Agency (EMA) is beginning a through analysis of the latest data on the cardiovascular risks from non-selective NSAIDS (non-steroidal anti-inflammatory drugs), that are primarily used as pain killers. The case of Vioxx is well documented and lesser issues such as gastrointestinal irritation from Asprin are also well known…